Dr Katie Flanagan, Australia
Presentation title: Sex Differences in Immunity to Infections and Vaccines
Dr Katie Flanagan BA(Hons) MBBS DTM&H PhD CCST FRCP FRACP is an Adjunct Senior Lecturer in the Dept of Immunology at Monash University in Melbourne, Australia and Head of Infectious Diseases at Launceston General Hospital in Tasmania, Australia. She obtained a degree in Physiological Sciences from Oxford University in 1988, and her MBBS from the University of London in 1992. She is a UK and Australia accredited Infectious Diseases Physician. She is on the Editorial Board of the Transactions of the Royal Society of Tropical Medicine and Hygiene, is a council member of the Australasian Society for infectious Diseases (ASID), and Chair of the Immunology Subgroup of the World Association of Infectious Diseases and Immunological Disorders (WAidid). She did a PhD in malaria immunology based at Oxford University with field studies in The Gambia and Kenya (1997 – 2000). She was previously Head of Infant Immunology Research at the MRC Laboratories in The Gambia from 2005-11 where she conducted multiple immunological studies in neonates and infants. Her research aims to understand how the infant immune system develops in response to vaccines and infections encountered in early life.
Dr Susan Huang, United States
Presentation title: Decolonization Trials: The Hospital and Beyond
Dr Susan Huang is a Professor of Infectious Diseases at the University of California, Irvine. She completed her medical degree at John Hopkins Universit School of Medicine and a Masters in Public Health at Harvard School of Public Health. Susan’s research focuses on the clinical epidemiology of highly antibiotic-resistant organisms including estimating the risk for infection and assessing practical means for prevention. Her work involves studying the risks of healthcare-associated transmission of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE), including both short and long-term sequelae due to these pathogens within and beyond the hospital stay. Her scope of research also includes an evaluation of inter-facility spread and containment of these pathogens, including the intersection of preventative measures on hospital networks, affiliated nursing homes, and surrounding communities. She has evaluated several strategies to mitigate transmission and disease, including active surveillance and institution of contact precautions, enhanced environmental cleaning, and, most recently, a leading large national cluster randomized trial of three ICU strategies to reduce MRSA infection.
Dr Jeanette Teo, Singapore
Presentation title: Molecular Aspects of Carbapenemase Producers in Singapore – The CaPES initiative
Dr Jeanette Teo completed her postdoctoral fellowship at the Novartis Institute of Tropical Diseases. There, she was part of a drug discovery programme, investigating new gene targets for the development of novel antibiotics against tuberculosis. After the postdoctoral stint, she joined the National University Hospital, Singapore, in 2005 where she has been working since as a scientific officer. Development of molecular diagnostic and identification assays for microorganisms and evaluation of novel technologies for clinical microbiology is what she is most involved with. Emerging antibiotic resistance in Gram-negatives and Mycobacterium are her pet research projects.